BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7624933)

  • 1. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
    Dowlati A; Honore P; Damas P; Deprez M; Delwaide J; Fillet G; Beguin Y
    Transplantation; 1995 Jul; 60(1):106-9. PubMed ID: 7624933
    [No Abstract]   [Full Text] [Related]  

  • 2. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver.
    Rosen HR; Martin P; Schiller GJ; Territo M; Lewin DN; Shackleton CR; Busuttil RW
    Liver Transpl Surg; 1996 May; 2(3):225-32. PubMed ID: 9346652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation.
    Norris S; Crosbie O; McEntee G; Traynor O; Nolan N; McCann S; Hegarty J
    Transplantation; 1997 May; 63(10):1521-4. PubMed ID: 9175821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
    Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
    Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation.
    Nimer SD; Milewicz AL; Champlin RE; Busuttil RW
    Transplantation; 1990 Apr; 49(4):819-21. PubMed ID: 2326879
    [No Abstract]   [Full Text] [Related]  

  • 6. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
    Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
    Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
    El-Sayed MH; El-Haddad A; Fahmy OA; Salama II; Mahmoud HK
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1347-54. PubMed ID: 15618844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation.
    Rhodes DF; Lee WM; Wingard JR; Pavy MD; Santos GW; Shaw BW; Wood RP; Sorrell MF; Markin RS
    Gastroenterology; 1990 Aug; 99(2):536-8. PubMed ID: 2365200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic complications after bone marrow transplantation.
    Mieli-Vergani G
    Bone Marrow Transplant; 1993; 12 Suppl 1():96-7. PubMed ID: 8374577
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.
    Remberger M; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3533-4. PubMed ID: 8540087
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatic complications of bone marrow transplantation].
    Martí Carvajal A
    G E N; 1991; 45(4):329-34. PubMed ID: 1843969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
    Hägglund H; Ringdén O; Ljungman P; Winiarski J; Ericzon B; Tydén G
    Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease.
    Rajvanshi P; McDonald GB
    Liver Transpl; 2001 Feb; 7(2):154-7. PubMed ID: 11172402
    [No Abstract]   [Full Text] [Related]  

  • 14. Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation.
    Figuera A; Tomás JF; Otero MJ; Moreno E; García I; Fernández-Rañada JM
    Am J Hematol; 1996 May; 52(1):68-9. PubMed ID: 8638625
    [No Abstract]   [Full Text] [Related]  

  • 15. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation.
    Bunin N; Leahey A; Dunn S
    Transplantation; 1996 Feb; 61(4):664-6. PubMed ID: 8610401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation: acute and late complications.
    Tabbara IA
    Anticancer Res; 1996; 16(2):1019-26. PubMed ID: 8687093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
    Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
    Mehta J; Powles R; Horton C; Milan S; Singhal S; Treleaven J
    Bone Marrow Transplant; 1995 Jun; 15(6):853-8. PubMed ID: 7581080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver dysfunction in the early post-bone marrow transplant period.
    Storek J
    Cas Lek Cesk; 1996 May; 135(10):295-8. PubMed ID: 8697490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe noninfectious acute lung injury in early phase of bone marrow transplantation.
    Gruson D; Hilbert G; Vargas F; Boiron JM; Pigneux A; Reiffers J; Gbikpi-Benissan G; Cardinaud JP
    Intensive Care Med; 1998 May; 24(5):536. PubMed ID: 9660275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.